Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 1109

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9B
Chunk 1109
---
10.6
     
    Amendment
    No. 1, dated April 20, 2023, to Amended and Restated Limited License Agreement between MIRA Pharmaceuticals, Inc. and MyMD Pharmaceuticals,
    Inc. (incorporated by reference to Exhibit 10.6 to Form S-1 filed July 28, 2023).
  
    10.7+
     
    Employment Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Erez Aminov (incorporated by reference to Exhibit 10.7 to Form S-1 filed July 28, 2023).
  
    10.8+
     
    Amendment
    to Employment Agreement, August 28, 2023, between MIRA Pharmaceuticals, Inc. and Erez Aminov (incorporated by reference to Exhibit
    10.1 to the Current Report on Form 8-K filed August 31, 2023).
  
    10.9+
     
    Employment
    Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Michelle Yanez (incorporated by reference to Exhibit 10.8
    to Form S-1 filed July 28, 2023).
  
    10.10
     
    Promissory
    Note and Loan Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (incorporated by reference
    to Exhibit 10.10 to Form S-1 filed July 28, 2023).
  
    10.11
     
    Registration
    Rights Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (incorporated by reference to Exhibit
    10.11 to Form S-1 filed July 28, 2023).
  
    10.12
     
    Agreement
    for Shared Lease Costs, dated April 1, 2023, between MIRA Pharmaceuticals, Inc., Telomir Pharmaceuticals, Inc., and MIRALOGX LLC
    (incorporated by reference to Exhibit 10.12 to Form S-1 filed July 28, 2023).

86

    10.13
     
    Exclusive
    License Agreement, by and between the Company and MIRALOGX, dated as of November 30